J. Medin

发表

Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS

M. Dwyer, R. Zivadinov, B. Weinstock-Guttman, 2017, American Journal of Neuroradiology.

Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study.

M. Dwyer, R. Zivadinov, B. Weinstock-Guttman, 2019, Multiple sclerosis and related disorders.

Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis

J. Korn, M. Olson, V. Risson, 2016, Journal of medical Internet research.

Responsiveness of AF6, a new, short, validated, atrial fibrillation-specific questionnaire—symptomatic benefit of direct current cardioversion

A. Bengtson, N. Edvardsson, J. Medin, 2010, Journal of Interventional Cardiac Electrophysiology.

Quality of life in people with type 2 diabetes in the 3years following initiation of second-line therapy: The DISCOVER study.

K. Khunti, I. Shimomura, M. Gomes, 2022, Diabetes research and clinical practice.

An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice—The MS‐MRIUS Study

M. Dwyer, R. Zivadinov, B. Weinstock-Guttman, 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Establishing pathological cut-offs for lateral ventricular volume expansion rates

M. Dwyer, R. Zivadinov, E. Havrdová, 2018, NeuroImage: Clinical.

Feasibility of Brain AtrophyMeasurement in Clinical Routine without Prior Standardization of theMRI Protocol : Results fromMS-MRIUS , a Longitudinal Observational , Multicenter Real-World Outcome Study in Patients with Relapsing-RemittingMS

M. Dwyer, B. Weinstock-Guttman, N. Bergsland, 2017 .

Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations

J. Medin, N. Foskett, Sue Rees, 2022, Vaccine.

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA

B. Tackenberg, T. Ziemssen, S. Schmidt, 2017, Neurotherapeutics.

Department of Error

J. Medin, L. Atwoli, Prakash Bhuyan, 2021, The Lancet.

An apple a day keeps the doctor away: Interdisciplinary approaches to solving major public health threats

A. Krettek, J. Medin, 2008, Scandinavian journal of public health.

Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis

H. Mullerova, J. Medin, Magnus Nord, 2021, The Lancet.

No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study

R. Zivadinov, B. Weinstock-Guttman, J. Korn, 2018, Current medical research and opinion.

Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study

Robert Zivadinov, Bianca Weinstock-Guttman, R. Zivadinov, 2017, CNS Drugs.

Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis.

Á. Lanas, E. Mills, J. Medin, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study

K. Hedman, E. Wittbrodt, A. Niklasson, 2020, Journal of medical Internet research.

Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study (Preprint)

K. Hedman, E. Wittbrodt, A. Niklasson, 2020 .

Multiple sclerosis in the real world: A systematic review of fingolimod as a case study.

T. Ziemssen, J. Medin, C. Couto, 2017, Autoimmunity reviews.

Sick leave, disability pension and health-care-seeking behaviour prior to stroke, among people aged 30–65: A case–control study

A. Nordlund, K. Ekberg, J. Medin, 2007, Brain injury.

Increasing Stroke Incidence in Sweden Between 1989 and 2000 Among Persons Aged 30 to 65 Years: Evidence From the Swedish Hospital Discharge Register

A. Nordlund, K. Ekberg, J. Medin, 2004, Stroke.

Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS‐MRIUS

M. Dwyer, R. Zivadinov, B. Weinstock-Guttman, 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Development and Validation of the AFSymp™: An Atrial Fibrillation-Specific Measure of Patient-Reported Symptoms

K. Coyne, N. Edvardsson, J. Medin, 2014, The Patient - Patient-Centered Outcomes Research.

Stroke patients' experiences of return to work

K. Ekberg, J. Medin, J. Barajas, 2006, Disability and rehabilitation.

Organisational change, job strain and increased risk of stroke? A pilot study.

J. Eklund, A. Nordlund, K. Ekberg, 2008, Work.

Identifying Non-Responders to Brace Therapies in Multiple Sclerosis using Advanced Predictive Models

J. Rigg, V. Risson, J. Medin, 2016 .

The psychosocial work environment is associated with risk of stroke at working age.

N. Karlsson, K. Ekberg, J. Medin, 2017, Scandinavian journal of work, environment & health.

Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL

T. Ziemssen, S. Vormfelde, J. Medin, 2017, PloS one.

Patient‐reported outcomes in multiple sclerosis: a systematic comparison of available measures

J. Medin, A. Callan, H. Sharma, 2017, European journal of neurology.

Background rate estimations for thrombosis with thrombocytopaenia: challenges in evaluating rare safety signals following vaccination in real time during a pandemic

R. Hubbard, J. Medin, Magnus Nord, 2023, BMJ Open.

W. Rathmann, K. Khunti, I. Shimomura, 2021, Diabetes Research and Clinical Practice.

Methods and rationale of the DISCOVER CKD global observational study

J. Carrero, D. Wheeler, H. Heerspink, 2021, Clinical kidney journal.

T1146 A Systematic Review of the Risk of Upper Gastrointestinal Complications Among Patients on Low-Dose Aspirin With Additional Risk Factors

A. Levy, Á. Lanas, J. Medin, 2010 .

Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Brace: A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies.

T. Ziemssen, S. Vormfelde, J. Medin, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Work Productivity and use of Disease-Modifying Therapies in Multiple Sclerosis: Results From A Patient Survey Accessed Through Social Media

J. Korn, M. Olson, J. Medin, 2016 .

Health promotion and rehabilitation: a case study

P. Bendtsen, K. Ekberg, J. Medin, 2003, Disability and rehabilitation.

R. Zivadinov, B. Weinstock-Guttman, J. Korn, 2018, Current medical research and opinion.

Estimated prevalence of secondary progressive multiple sclerosis in the USA and Europe: results from a systematic literature search (P2.380)

J. Medin, H. Sharma, V. Khurana, 2018, Neurology.

Linkage Analysis of Multiple-Sclerosis Patient Data From Social-Media Surveys And Claims Databases Identifies A Representative Population For Real-Life Outcomes Research

J. Korn, M. Olson, V. Risson, 2016 .